Crea il mio profilo
Accesso pubblico
Visualizza tutto28 articoli
6 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Marwin SeglerMicrosoft Research AI4ScienceEmail verificata su microsoft.com
- Peter ErtlLeading Scientist at NovartisEmail verificata su peter-ertl.com
- Joshua MeyersProtein Engineering AI Lead, SyntenyAIEmail verificata su synteny.ai
- Sarah R. LangdonPhD Student, The Institute of Cancer ResearchEmail verificata su icr.ac.uk
- Paul WorkmanChief Executive & President, Institute of Cancer Research, LondonEmail verificata su icr.ac.uk
- Richard BaylissProfessor, University of LeedsEmail verificata su leeds.ac.uk
- Lewis R. VidlerComputational Medicinal Chemist, UCBEmail verificata su ucb.com
- Stefan KnappUniversity of FrankfurtEmail verificata su pharmchem.uni-frankfurt.de
- Yi MokBenevolentAIEmail verificata su benevolent.ai
- Nicholas FirthEmail verificata su ucl.ac.uk
- Christos A NicolaouSenior Scientific Director, Computational Drug Discovery, Novo NordiskEmail verificata su novonordisk.com
- Richard A. LewisNovartis, BaselEmail verificata su novartis.com
- Isaac WestwoodThe Institute of Cancer ResearchEmail verificata su icr.ac.uk
- Jeremy L. JenkinsUS Head Discovery Sciences, Novartis Institutes for BioMedical ResearchEmail verificata su novartis.com
- Oleg FedorovUniversity of OxfordEmail verificata su cmd.ox.ac.uk
- Panagis FilippakopoulosAssociate Professor, Oxford UniversityEmail verificata su sgc.ox.ac.uk
- Fabio BroccatelliDirector at Altos LabsEmail verificata su altoslabs.com
- George PapadatosHead of Data, Syngenta CP R&DEmail verificata su syngenta.com
- Ruth BrenkUniversity of BergenEmail verificata su uib.no
- Pascal FuretDirector and leading scientist at NovartisEmail verificata su novartis.com